Patient outcomes and health economics ever more important in innovation strategies
This article was originally published in Scrip
Given the widespread acknowledgement that the UK "could do better" on mental health, it was encouraging that the issue was one of two new additions on the agenda of the recent World Leaders in Medical Innovations conference, held in Wembley Stadium, London. IT was the other new area.
You may also be interested in...
Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Germany has ramped up its COVID-19 testing capacity to 260,000 per week, and still has a relatively low death rate from the virus. The country's diagnostics industry says it is ready to play its part “24/7.”